{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/63d3fa79963ae60011080fc8/63d3fa80cf2e4c0010ee8f17?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Future of Vaccines with GSK’s Emma Walmsley","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/63d3fa79963ae60011080fc8/1693400365760-0d437b7b1e64b96395e82764f04a32ed.jpeg?height=200","description":"<p><em>The CEO of GSK (formerly GlaxoSmithKline), Dame Emma Walmsley, joins hosts Omar Abbosh and&nbsp;</em><a href=\"http://will.i.am/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>will.i.am</em></a><em>&nbsp;to discuss how innovation and biotechnology are changing the future of medicine. GSK has a history of discovering game-changing medical therapies, from pharmaceuticals to consumer healthcare products. Now the global company is spinning off its consumer product business into an independent company, allowing GSK to focus fully on drug development and vaccines.</em></p><p><br></p><p><a href=\"https://query.prod.cms.rt.microsoft.com/cms/api/am/binary/RWXhoq\" rel=\"noopener noreferrer\" target=\"_blank\">Read the transcript</a></p>","author_name":"Microsoft"}